Influenza Management With Polyherbal Formulation
- Status
- UNKNOWN
- Phase
- NA
Clinical Trials Related to Influenza
Related studies linked through entity extraction aliases.
Safety, Tolerability, and Immunogenicity of VAL-339851 in Healthy Adult Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Immunogenicity and Safety of the Shenzhen Trivalent Inactivated Influenza Vaccine Versus a Trivalent Influenza Vaccine Comparator in Chinese Subjects 18 to 59 Years
- Status
- COMPLETED
- Phase
- PHASE4
A Phase III, Randomized, Double-Blind, Placebo Controlled Trial to Evaluate the Efficacy and Safety of Nitazoxanide in the Treatment of Uncomplicated Influenza
- Status
- COMPLETED
- Phase
- PHASE3
Prevention of Influenza and Other Wintertime Respiratory Viruses Among Healthcare Professionals in Israel
- Status
- COMPLETED
- Phase
- N/A
Safety and Immunogencity of H7N9 Influenza Antigen With 2 Adjuvant Formulations in Healthy Adults in Brazil
- Status
- COMPLETED
- Phase
- PHASE1
Age and Response to Flu Vaccines
- Status
- COMPLETED
- Phase
- PHASE4
Early Flu Shots in SOT
- Status
- WITHDRAWN
- Phase
- N/A
Immune Responses in Health Care Personnel
- Status
- RECRUITING
- Phase
- N/A
Lot-to-lot Consistency of a Plant-Derived Quadrivalent Virus-Like Particles Influenza Vaccine in Healthy Adults
- Status
- COMPLETED
- Phase
- PHASE3
Co-Administration of AS03 Adjuvanted A/H7N9 IIV With IIV4
- Status
- COMPLETED
- Phase
- PHASE2
Effects of Aging on Primary and Secondary Vaccine Responses
- Status
- COMPLETED
- Phase
- PHASE1
Safety and Immunogenicity of Fluzone® Quadrivalent and Fluzone® High-Dose, Influenza Vaccines
- Status
- COMPLETED
- Phase
- PHASE4
Efficacy, Safety, and Immunogenicity of a Plant-Derived Quadrivalent Virus-Like Particles (VLPs) Influenza Vaccine in Adults
- Status
- COMPLETED
- Phase
- PHASE3
Improved Novel VaccIne CombinaTion InflUenza Study
- Status
- TERMINATED
- Phase
- PHASE2
Safety and Immunogenicity of a Live-attenuated Universal Flu Vaccine Followed by an Inactivated Universal Flu Vaccine
- Status
- COMPLETED
- Phase
- PHASE1
Evaluation of the Safety and Immunogenicity of a Recombinant Trivalent Nanoparticle Influenza Vaccine With Matrix M-1 Adjuvant (NanoFlu)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Flu2Text: Text Message Reminders for 2nd Dose of Influenza Vaccine
- Status
- COMPLETED
- Phase
- NA
Safety and Immunogenicity of High-Dose Quadrivalent Influenza Vaccine in Participants ≥65 Years in the US
- Status
- COMPLETED
- Phase
- PHASE3
FluSAFE: Flu SMS Alerts to Freeze Exposure
- Status
- COMPLETED
- Phase
- NA